Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• Cupid Hits Fresh 52-Week High on Rs 128 Crore Block Deal
• Ather Energy Slips Despite $200 Million Fundraise Buzz
• Shyam Metalics Slips Even as Q1 Volumes Surge
• Unihealth Hospitals Shares Hit 5% Upper Circuit on Plans to Raise Stake 
• Oswal Pumps, Shakti Pumps Rally on Solar Order Wins

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.